San Francisco, California, US

Cell therapy development and manufacturing facility

Located adjacent to numerous oncology hospitals in the Bay Area and approximately 15 minutes from the San Francisco International Airport, this 44,000 sq. ft., state-of-the-art facility provides full-service cell therapy process and analytical development capabilities and clinical and commercial cGMP manufacturing services to customers across the US and globally. Our team has experience in a variety of modalities including autologous and allogeneic cell therapies, viral and non-viral modified gene delivery systems, and numerous cell types (T-cells, NK cells, iPSCs, MSCs, and more).

 

Capabilities

  • Cell isolation, modification, expansion, fill-finish, and cryopreservation
  • AD/PD lab for process optimization, verification, and confirmation, as well as method development/qualification and assay optimization
  • QC lab to support in-process, safety, and final product testing 
  • Individual, user-configurable production suites with self-contained HVAC and related infrastructure to protect against cross-contamination 
  • Collaboration center to provide non-GMP space for training scientists and operators both for tech transfer and process development
  • Support for phase I through commercial manufacturing 
  • Potential to expand based on customer needs

777 Mariposa St
San Francisco, CA 94107

Helpful Resources